SynPhNe Company Profile

Background

Overview

SynPhNe, established in 2013, is a pioneering company specializing in neuro-integrative wearable technology aimed at enhancing rehabilitation and performance across various domains. The company is headquartered in Singapore, with additional offices in Mumbai, India, and Somerville, New Jersey, USA. SynPhNe's mission is to empower individuals by providing innovative solutions that facilitate recovery and improve quality of life. Their vision is to return the first line of prevention and cure for chronic disability and disease to communities and families by 2030.

Mission and Vision

• Mission: To empower individuals worldwide in their quest for better health and fulfilled lives through effective technologies, modern brain science, and ancient wisdom about the nature of the mind.

• Vision: To return the first line of prevention and cure for chronic disability and disease to communities and families by 2030.

Primary Area of Focus

SynPhNe focuses on developing wearable solutions that integrate brain and muscle training to aid in the rehabilitation of individuals affected by stroke, traumatic brain injury (TBI), learning disabilities, and other neurological conditions. Their technology leverages real-time EEG and EMG data to create a self-correcting learning loop, providing insights that allow for patient-specific rehabilitation.

Industry Significance

Operating within the medical equipment manufacturing industry, SynPhNe is at the forefront of integrating wearable technology with neurorehabilitation. Their innovative approach addresses the growing need for effective, accessible, and personalized rehabilitation solutions, positioning them as a significant player in the neurotechnology sector.

Key Strategic Focus

Core Objectives

• Innovative Rehabilitation: Develop and deploy wearable devices that facilitate brain-muscle training, enhancing recovery outcomes for individuals with neurological impairments.

• Global Expansion: Extend the reach of their technology to diverse markets, including Asia, the United States, and Europe, to impact a broader patient population.

• Clinical Validation: Conduct rigorous clinical studies to validate the efficacy of their devices, ensuring they meet the highest standards of medical practice.

Specific Areas of Specialization

• Neurorehabilitation: Focusing on stroke and TBI recovery, SynPhNe's technology aims to restore cognitive and motor functions through integrated training systems.

• Sports Performance: Applying their wearable solutions to enhance athletic performance, particularly in disciplines requiring precision and coordination.

• Learning Disabilities: Utilizing their technology to support individuals with learning challenges, aiming to improve cognitive functions and learning outcomes.

Key Technologies Utilized

• Wearable Neurotechnology: Devices that monitor and stimulate brain and muscle activity to promote neuroplasticity and functional recovery.

• Real-Time Data Analytics: Processing EEG and EMG signals to provide immediate feedback and adjust training protocols accordingly.

• AI-Driven Insights: Employing artificial intelligence to analyze complex data sets, offering personalized rehabilitation strategies.

Primary Markets Targeted

• Healthcare Providers: Hospitals, clinics, and rehabilitation centers seeking advanced tools for patient recovery.

• Sports Organizations: Athletic programs and academies aiming to enhance performance and prevent injuries.

• Educational Institutions: Schools and learning centers addressing learning disabilities and cognitive development.

Financials and Funding

Funding History

SynPhNe has raised a total of $5 million in funding, with the most recent round occurring two years ago.

Notable Investors

• IntuitiveVC: A venture capital firm known for investing in innovative healthcare technologies.

• NTUitive: The innovation and enterprise company of Nanyang Technological University, supporting startups and spin-offs.

Utilization of Capital

The funds have been allocated towards research and development, clinical trials, market expansion, and enhancing manufacturing capabilities to meet growing demand.

Pipeline Development

Key Pipeline Candidates

• SynPhNe Xpert: A platform designed for healthcare providers, including hospitals and clinics, to integrate SynPhNe's technology into their rehabilitation programs.

• SynPhNe eNabl: A home-use device that allows individuals to engage in neurorehabilitation exercises independently, promoting continuous recovery outside clinical settings.

Stages of Development

• Clinical Trials: Ongoing studies to validate the effectiveness of their devices in various rehabilitation contexts.

• Regulatory Approvals: Achieved FDA Class I and HSA Class A certifications, facilitating broader market access.

Target Conditions

• Neurological Impairments: Including stroke, TBI, and cerebral palsy.

• Learning Disabilities: Such as dyslexia and ADHD.

• Age-Related Cognitive Decline: Addressing memory and functional decline in the elderly.

Anticipated Milestones

• Product Launches: Introduction of SynPhNe Xpert and SynPhNe eNabl to the market.

• Clinical Study Publications: Expected publications in 2026 detailing the outcomes of their clinical trials.

Technological Platform and Innovation

Proprietary Technologies

• Neuro-Integrative Wearables: Devices that simultaneously train brain and muscle functions to enhance neuroplasticity and recovery.

• Real-Time Biofeedback Systems: Providing immediate feedback to users, facilitating self-regulation and accelerated rehabilitation.

Significant Scientific Methods

• Neuroplasticity Training Models: Utilizing principles of neuroplasticity to promote functional recovery in individuals with neurological impairments.

• Data-Driven Rehabilitation Protocols: Employing machine learning algorithms to analyze patient data and optimize therapy regimens.